Nektar Therapeutics plunges 29% after hours on mid-stage lupus treatment failure Posted on February 24, 2023 By Charlielikes Stock Market
Applied Molecular Transport oral ulcerative colitis candidate fails in mid-stage trial Posted on December 22, 2022 By Charlielikes Stock Market
BioVie gains on positive results from mid-stage trials in Parkinson’s & Alzheimer’s disease Posted on December 5, 2022 By Charlielikes Stock Market